Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects With Autoinflammatory Diseases: A Therapeutic Approach to Study Pathogenesis
Phase of Trial: Phase II
Latest Information Update: 31 May 2013
At a glance
- Drugs Rilonacept (Primary)
- Indications Adult-onset Still's disease; Inflammation
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Dec 2010 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 28 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.